Add Company
Join Now

Chromis Therapeutics Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Chromis Therapeutics's estimated annual revenue is currently $310k per year.(i)
  • Chromis Therapeutics's estimated revenue per employee is $155,000

Employee Data

  • Chromis Therapeutics has 2 Employees.(i)
  • Chromis Therapeutics grew their employee count by 0% last year.

Chromis Therapeutics's People

NameTitleEmail/Phone
1
VP Translational Research and Clinical DevelopmentReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is Chromis Therapeutics?

Chromis Therapeutics, Inc. is a San Diego-based biopharmaceutical company, focused on the development of curative treatments for chronic HBV infection, based on its advanced proprietary drug design and discovery platform. The company is seeking investment to advance its novel cccDNA inhibitor (CHR101), viral entry and viral capsid assembly inhibitor lead candidates for the treatment of chronic HBV. CHR101 has the potential to eradicate HBV and to efficiently cure chronically infected HBV patients, as compared to drugs currently on the market. CHR101's activity is supported by a robust discovery preclinical data package.

keywords:N/A

N/A

Total Funding

2

Number of Employees

$310k

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0M2-50%$1.3M
#2
$0M20%$2.2M
#3
$0.1M20%N/A
#4
$0.3M2-50%N/A
#5
$0.2M2-50%N/A